Transportability of comparative effectiveness and cost-effectiveness between countries

Value in Health

Volumn 13, Issue SUPPL. 1, 2010, Pages

  Briggs, Andrew ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

QALY; regional estimates; sub group analysis; transferability

Indexed keywords

CLINICAL PRACTICE; COMPARATIVE EFFECTIVENESS; CONSUMER ATTITUDE; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; EPIDEMIOLOGY; HEALTH CARE PERSONNEL; PATIENT ATTITUDE; PERSONNEL MANAGEMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT SURVEY; STATISTICAL MODEL;

EID: 77954323678     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2010.00751.x     Document Type: Short Survey

References (16)

1. Briggs AH, Glick H, Lozano-Ortega G, et al. Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study. Eur Respir J 2010 25 : 532 539.
2. O'Brien BJ. A tale of two (or more) cities: geographic transferability of pharmacoeconomic data. Am J Manag Care 1997 3 (Suppl S33 9.
3. McAlister FA. Commentary: relative treatment effects are consistent across the spectrum of underlying risks. usually. Int J Epidemiol 2002 31 : 76 7.
4. Warrillow SJ, Bellomo R, Davey P, Birkmeyer J. Major surgery in Victoria and the United States: a comparison of hospital mortality in older patients. Crit Care Resusc 2008 10 : 288 295.
5. Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008 372 : 139 144.
6. Glick HA, Polsky D, Willke RJ, et al. Comparison of the use of medical resources and outcomes in the treatment of aneurysmal subarachnoid hemorrhage between Canada and the United States. Stroke 1998 29 : 351 358.
7. Reed SD, Anstrom KJ, Bakhai A, et al. Conducting economic evaluations alongside multinational clinical trials: toward a research consensus. Am Heart J 2005 149 : 434 443.
8. Willke RJ, Glick HA, Polsky D, Schulman K. Estimating country-specific cost-effectiveness from multinational clinical trials. Health Econ 1998 7 : 481 493.
9. Cook JR, Drummond M, Glick H, Heyse JF. Assessing the appropriateness of combining economic data from multinational clinical trials. Stat Med 2003 22 : 1955 1976.
10. Gail M, Simon R. Testing for qualitative interactions between treatment effects and patient subsets. Biometrics 1985 41 : 361 372.
11. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994 344 : 1383 1389.
12. Jonsson B, Johannesson M, Kjekshus J, et al. Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S). Eur Heart J 1996 17 : 1001 1007. (Pubitemid 26252516)
13. Grieve R, Nixon R, Thompson SG. Bayesian hierarchical models for cost-effectiveness analyses that use data from cluster randomized trials. Med Decis Making 2010 30 : 163 175.
14. Manca A, Lambert PC, Sculpher M, Rice N. Cost-effectiveness analysis using data from multinational trials: the use of bivariate hierarchical modeling. Med Decis Making 2007 27 : 471 490.
15. Willan AR, Pinto EM, O'Brien BJ, et al. Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis. Health Econ 2005 14 : 327 338.
16. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977 296 : 716 721.